Will manufacture and export but not sell weight-loss drug in India, Dr. Reddy’s tells Delhi HC
The case concerns an alleged violation of Novo Nordisk’s patent on its diabetes medication, semaglutide. | Photo Credit: Hollie Adams Dr. Reddy’s Laboratories Ltd. (DRL) and OneSource Specialty Pharma have…